Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ultralife (ULBI) EBITDA Margin (2016 - 2025)

Ultralife has reported EBITDA Margin over the past 16 years, most recently at 15.48% for Q4 2025.

  • Quarterly results put EBITDA Margin at 15.48% for Q4 2025, down 1382.0% from a year ago — trailing twelve months through Dec 2025 was 2.63% (down 626.0% YoY), and the annual figure for FY2025 was 2.63%, down 626.0%.
  • EBITDA Margin for Q4 2025 was 15.48% at Ultralife, down from 3.36% in the prior quarter.
  • Over the last five years, EBITDA Margin for ULBI hit a ceiling of 7.61% in Q4 2023 and a floor of 15.48% in Q4 2025.
  • Median EBITDA Margin over the past 5 years was 2.53% (2023), compared with a mean of 0.5%.
  • Biggest five-year swings in EBITDA Margin: tumbled -1422bps in 2021 and later skyrocketed 947bps in 2023.
  • Ultralife's EBITDA Margin stood at 4.06% in 2021, then tumbled by -43bps to 5.81% in 2022, then soared by 231bps to 7.61% in 2023, then crashed by -122bps to 1.66% in 2024, then tumbled by -832bps to 15.48% in 2025.
  • The last three reported values for EBITDA Margin were 15.48% (Q4 2025), 3.36% (Q3 2025), and 3.61% (Q2 2025) per Business Quant data.